Supply of Sodium Bicarbonate Injection 4.2%, 5 mL

The contract obligates the contractor to manufacture, package, label, and deliver sterile Sodium Bicarbonate Injection 4.2% in 5 mL vials in full compliance with all federal medical, hazardous materials, and defense regulations. The product is identified by NSN 6505015052382 and must be prepared and handled according to stringent pharmaceutical and military standards to ensure safety and efficacy. All shipments are destined for Fort Bragg, North Carolina, with the final delivery point specified as the military installation’s designated supply receiving area, and the product must meet exacting quality control requirements throughout the production and logistics chain. This is a subcontract solicitation issued under the Department of Defense’s Medical Supply Chain PHARM FSA, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing as the primary industry classification. The solicitation was posted on July 15, 2026, and responses are due by July 21, 2026, creating a narrow five-day window for interested parties to submit proposals. The contract requires strict adherence to defense procurement protocols, including documentation, packaging, labeling, and transportation standards for hazardous pharmaceuticals, ensuring complete traceability and regulatory compliance from production through delivery. Failure to meet any specification could result in rejection of the shipment or contract termination.